| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |